During the past decade, Laurelton Heart Specialist conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Laurelton Heart Specialist" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Eidos Therapeutics, a BridgeBio company" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored and "Zoll Medical Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Laurelton Heart Specialist" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Laurelton Heart Specialist" are "Heart Failure" (3 trials), "Amyloid Cardiomyopathy" (1 trials), "Amyloidosis" (1 trials), "Cardiomyopathies" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Laurelton Heart Specialist" in a lesser frequency.

Most popular intervention types in "Laurelton Heart Specialist" are "Drug" (6 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Acoramidis (AG10)" (1 trials), "Empagliflozin" (1 trials), "Empagliflozin high dose" (1 trials) and "Empagliflozin low dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Laurelton Heart Specialist" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Laurelton Heart Specialist". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Laurelton Heart Specialist, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Laurelton Heart Specialist, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".